{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:37:40Z","timestamp":1756463860804},"reference-count":15,"publisher":"Elsevier BV","issue":"11","content-domain":{"domain":["jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.jocn.2012.12.016","type":"journal-article","created":{"date-parts":[[2013,7,29]],"date-time":"2013-07-29T19:45:25Z","timestamp":1375127125000},"page":"1618-1619","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Successful treatment of infliximab-associated immune-mediated sensory polyradiculopathy with intravenous immunoglobulin"],"prefix":"10.1016","volume":"20","author":[{"given":"Hiroya","family":"Naruse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Etoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Hida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Kaida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Shiio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2012.12.016_b0005","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00415-010-5591-7","article-title":"Neurological adverse events associated with anti-tumor necrosis factor \u03b1 treatment","volume":"257","author":"Tristano","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2012.12.016_b0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrneurol.2011.1","article-title":"Monoclonal antibody therapy-associated neurological disorders","volume":"7","author":"Bosch","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jocn.2012.12.016_b0015","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/ard.2006.066787","article-title":"Optic neuritis occurring with anti-tumour necrosis factor alpha therapy","volume":"66","author":"Simsek","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jocn.2012.12.016_b0020","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/mus.21051","article-title":"Lewis-Sumner syndrome associated with infliximab therapy in rheumatoid arthritis","volume":"38","author":"Hooper","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.12.016_b0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/mus.20924","article-title":"Tumor necrosis factor-alpha antagonists and neuropathy","volume":"37","author":"Stubgen","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.12.016_b0030","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/art.21814","article-title":"Guillain-Barre and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy","volume":"54","author":"Shin","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jocn.2012.12.016_b0035","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1212\/01.WNL.0000158681.29117.8B","article-title":"Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockers","volume":"64","author":"Richez","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.12.016_b0040","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1085-9489.2005.00053.x","article-title":"Multifocal motor neuropathy during treatment with infliximab","volume":"10","author":"Cocito","year":"2005","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.jocn.2012.12.016_b0045","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/mus.21584","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists","volume":"41","author":"Alshekhlee","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2012.12.016_b0050","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1007\/s00415-012-6452-3","article-title":"Isolated motor conduction block associated with infliximab","volume":"259","author":"Michell","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2012.12.016_b0055","first-page":"1018","article-title":"Neurological complications of infliximab","volume":"33","author":"Jarand","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jocn.2012.12.016_b0060","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s10067-006-0317-z","article-title":"Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment","volume":"26","author":"Tektonidou","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jocn.2012.12.016_b0065","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jneuroim.2006.09.013","article-title":"Anti-ganglioside complex antibodies associated with severe disability in GBS","volume":"182","author":"Kaida","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2012.12.016_b0070","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1212\/01.WNL.0000142507.12763.58","article-title":"Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia","volume":"63","author":"Sinnreich","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.12.016_b0075","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.4049\/jimmunol.167.12.6821","article-title":"In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL","volume":"167","author":"Via","year":"2001","journal-title":"J Immunol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586813001215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586813001215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T08:28:42Z","timestamp":1539505722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586813001215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0967586813001215"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2012.12.016","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment of infliximab-associated immune-mediated sensory polyradiculopathy with intravenous immunoglobulin","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2012.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}